DGHMC
Dalton, Greiner, Hartman, Maher & Co’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-497,625
| Closed | -$17M | – | 184 |
|
2017
Q1 | $17M | Sell |
497,625
-1,940
| -0.4% | -$66.4K | 0.97% | 43 |
|
2016
Q4 | $16.2M | Sell |
499,565
-19,928
| -4% | -$647K | 0.95% | 43 |
|
2016
Q3 | $17.6M | Sell |
519,493
-197,611
| -28% | -$6.69M | 1.14% | 19 |
|
2016
Q2 | $25.2M | Sell |
717,104
-100,897
| -12% | -$3.55M | 1.56% | 4 |
|
2016
Q1 | $24.2M | Sell |
818,001
-386,624
| -32% | -$11.5M | 1.5% | 5 |
|
2015
Q4 | $38.9M | Sell |
1,204,625
-128,068
| -10% | -$4.13M | 2.23% | 2 |
|
2015
Q3 | $41.9M | Sell |
1,332,693
-116,697
| -8% | -$3.67M | 2.35% | 2 |
|
2015
Q2 | $48.6M | Sell |
1,449,390
-25,175
| -2% | -$844K | 2.52% | 1 |
|
2015
Q1 | $51.3M | Sell |
1,474,565
-24,875
| -2% | -$865K | 2.88% | 1 |
|
2014
Q4 | $46.7M | Buy |
1,499,440
+201,581
| +16% | +$6.28M | 2.58% | 1 |
|
2014
Q3 | $38.4M | Buy |
+1,297,859
| New | +$38.4M | 2.18% | 1 |
|